NCT03866928View on ClinicalTrials.gov

Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

April 5, 2019

Study Completion Date

April 5, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Stiripentol

1500 mg of stiripentol b.i.d.

Trial Locations (1)

Unknown

ATC, Liège

Sponsors

Lead Sponsor

Biocodex
All Listed Sponsors
lead

Biocodex

INDUSTRY